Issue 2/2004
Content (9 Articles)
The Addition of Manual Lymph Drainage to Compression Therapy For Breast Cancer Related Lymphedema: a Randomized Controlled Trial
Margaret L. McNeely, David J. Magee, Alan W. Lees, Keith M. Bagnall, Mark Haykowsky, John Hanson
Microwave Detection of Metastasized Breast Cancer Cells in the Lymph Node; Potential Application for Sentinel Lymphadenectomy
Jin Wook Choi, Jeiwon Cho, Yangsoo Lee, Jounghwa Yim, Byoungjoong Kang, Ki Keun Oh, Woo Hee Jung, Hee Jung Kim, Changyul Cheon, Hy-De Lee, Youngwoo Kwon
Duration of Signs and Survival in Premenopausal Women with Breast Cancer
Richard R. Love, Nguyen Ba Duc, Linda C. Baumann, Pham Thi Hoang Anh, Ta Van To, Zheng Qian, Thomas C. Havighurst
Trastuzumab Plus Tamoxifen: Anti-Proliferative and Molecular Interactions in Breast Carcinoma
Santiago Ropero, Javier Abel Menéndez, Alejandro Vázquez-Martín, Sagrario Montero, Hernán Cortés-Funes, Ramon Colomer
The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas
Karin Milde-Langosch, Heike Röder, Birte Andritzky, Bahriye Aslan, Gabriele Hemminger, Anja Brinkmann, Christoph M. Bamberger, Thomas Löning, Ana-Maria Bamberger
Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23
Stephanie R. Land, Jacek A. Kopec, Greg Yothers, Stewart Anderson, Richard Day, Gong Tang, Patricia A. Ganz, Bernard Fisher, Norman Wolmark
Is Stereotactic Large-Core Needle Biopsy Beneficial Prior to Surgical Treatment in BI-RADS 5 Lesions?
Lidewij E. Hoorntje, Petra H.M. Peeters, Willem P.T.M. Mali, Inne H.M. Borel Rinkes
Number of Metastatic Sentinel Nodes As Predictor of Axillary Involvement in Patients with Breast Cancer
Giorgio Zavagno, Gian Luca De Salvo, Fernando Bozza, Giuliano Scalco, Renato Marconato, Stefano Valletta, Carlo Racano, Paolo Burelli, Donato Nitti, Mario Lise
Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?
Keith N. Ogston, Iain D. Miller, Andrew C. Schofield, Andreas Spyrantis, Eleni Pavlidou, Tarun K. Sarkar, Andrew W. Hutcheon, Simon Payne, Steven D. Heys